Prostatis Group’s First Trust Enhanced Short Maturity ETF FTSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,722
Closed -$223K 168
2025
Q2
$223K Buy
+3,722
New +$223K 0.06% 149
2023
Q4
Sell
-41,844
Closed -$2.52M 133
2023
Q3
$2.52M Sell
41,844
-2,426,086
-98% -$145M 1.23% 17
2023
Q2
$2.52M Buy
2,467,930
+2,432,752
+6,916% +$145M 1.17% 20
2023
Q1
$2.09M Sell
35,178
-8,393
-19% -$500K 1.11% 20
2022
Q4
$2.59M Buy
43,571
+10,093
+30% +$600K 1.58% 17
2022
Q3
$1.99M Sell
33,478
-433,163
-93% -$25.7M 2.29% 15
2022
Q2
$27.7M Buy
+466,641
New +$27.8M 43.19% 1

Other funds holding FTSM

Prostatis Group's FTSM Position: Q3 2025 in Review

Prostatis Group sold out of First Trust Enhanced Short Maturity ETF (FTSM) in Q3 2025, closing a stake of 3,722 shares — an estimated $223K sold.

Prostatis Group first reported a position in FTSM in Q2 2022 and held it in 7 quarters. The position peaked at $27.7M in Q2 2022. 399 funds tracked by Wall St. Rank hold FTSM as of Q3 2025.

  • Prostatis Group reported no remaining First Trust Enhanced Short Maturity ETF position as of Q3 2025 after selling out during the quarter.
  • Prostatis Group sold 3,722 First Trust Enhanced Short Maturity ETF shares in Q3 2025, an estimated $223K.
  • Prostatis Group first reported a position in First Trust Enhanced Short Maturity ETF in Q2 2022 and held it in 7 quarters.
  • Prostatis Group's First Trust Enhanced Short Maturity ETF position peaked at $27.7M in Q2 2022.
  • 399 funds tracked by Wall St. Rank held First Trust Enhanced Short Maturity ETF as of Q3 2025.

Based on Prostatis Group's 13F filing for Q3 2025, filed 4 Nov 2025.